Targeting of UnControlled Hypertension in Emergency Department

NACompletedINTERVENTIONAL
Enrollment

574

Participants

Timeline

Start Date

February 19, 2019

Primary Completion Date

March 31, 2023

Study Completion Date

March 31, 2023

Conditions
HypertensionCardiovascular DiseasesVascular Diseases
Interventions
OTHER

HTN Educational Video

The video will educate participants in arm 2 about high BP, how it is diagnosed, and the importance of treating it to prevent secondary complications.

OTHER

Visual Echocardiogram Image Clips

Visual clips of age/gender-matched echocardiograms will be used to educate and motivate patients to change their behavior and improve their BP. We have found that real time visualization of cardiac ultrasound images with active discussion of findings is a significant patient motivator and empowerment tool, and was a significant factor in the success of our previous pilot study.

OTHER

Mobile Health and Remote BP monitoring

All participants randomized to the intervention group will receive an FDA-approved HBPM kit that includes the Nokia wireless (self-inflating) BPM+ monitor and Health Mate mobile app. The app automatically launches when the patient slips on the cuff and turns on the monitor to measure his/her BP. Synced data are automatically uploaded from the mobile app to the iCardia server of our study.

OTHER

Post-Acute Care HTN Transition consultation (PACHT-c)

All participants randomized to the E2 intervention will have a focused consultation with either a clinical pharmacist or an APN. During this consultation, the pharmacist/APN repeats the BP measurement; reviews the screening assessments; and reviews general principles of BP control including nutrition, exercise, and smoking cessation. BP will be managed according to the current published guidelines available at the time of funding regarding initiation of first-line antihypertensive medications. Patients with BP ≥160/100 mmHg may be started on antihypertensive medications by the provider during the consultation if appropriate.

Trial Locations (1)

60612

University of Illinois at Chicago, Chicago

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Illinois at Chicago

OTHER

NCT03749499 - Targeting of UnControlled Hypertension in Emergency Department | Biotech Hunter | Biotech Hunter